Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 3, 1998, Pages 276-282

  Merkel, C ^a   Morabito, A ^b   Sacerdoti, D ^a   Bolognesi, M ^b   Angeli, P ^a   Gatta, A ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Aminopyrine; Liver cirrhosis; Liver function; Prognosis

Indexed keywords

ALBUMIN; AMINOPHENAZONE; BILIRUBIN; CARBON 14; PROTHROMBIN;

ACCURACY; ADULT; AGED; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; BREATH ANALYSIS; CLINICAL TRIAL; DEATH; DISEASE COURSE; DISEASE SEVERITY; DRUG METABOLISM; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; PREDICTION; RATING SCALE; REGRESSION ANALYSIS; SURVIVAL; TIME;

AMINOPYRINE; BREATH TESTS; CARBON RADIOISOTOPES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0031856703     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Merkel C, Bolognesi M, Bellon S, Bianco S, Honisch B, Lampe H, et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 1992;33:836-42.
2. Pugh RNH, Murray-Lyon IM, Dawson IL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
3. Cox DR. Regression models and life tables (with discussion). J R StatSocB 1972;34:187-220.
4. Christensen E. Multivariate survival analysis using Cox's regression models. Hepatology 1987:7:1346-58.
5. Mather FJ, Simon RM, Clark GM, von Hoff DD. A method for the evaluation of dose-toxicity relationships in clinical trials. Stat Med 1989:8:813-23.
6. Chang HH, Lininger LL, Doyle JT, Maccubbin PA, Rothenberg RB. Application of Cox model as a predictor of relative risk of coronary heart disease in the Albany study. Stat Med 1990:9:287-92.
7. Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. Gastroenterology 1993; 105:1865-76.
8. Merkel C, Marchesini G, Fabbri A, Bianco S, Bianchi G, Enzo E, et al. The course of galactose elimination capacity in patients with alcoholic cirrhosis. Possible use as a surrogate marker for death. Hepatology 1996;24:820-3.
9. Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986;71:163-74.
10. Hepner GW, Vesell ES. Quantitative assessment of hepatic function by breath analysis after oral administration of 14-Caminopyrine. Ann Intern Med 1975;83:632-8.
11. Bircher J. Quantitative assessment of deranged hepatic function: a missed opportunity? Sem Liv Dis 1983;3:275-84.
12. Merkel C, Sacerdoti D, Finucci GF, Zuin R, Bazzerla G, Bolognesi M, et al. Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. Br J Clin Pharmacol 1986;21:713-9.
13. Christensen E, Schlichting P, Fauerholdt L, Juhl E, Poulsen H, Tygstrup N. Changes in laboratory variables with time in cirrhosis: prognostic and therapeutic significance. Hepatology 1985;5:843-53.
14. Dixon WJ, Brown MB, Engelman L, Frane JW, Hill MA, Jenrich RI, et al. BMDP statistical software. Berkeley, University of California Press, 1983.
15. Morabito A. AMS: a computer program for survival analysis, general linear models, and a stochastic survival model. Compstat 1986. Physica-Verlag, Heidelberg for IASC.
16. Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984:4:430-5.
17. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting shortterm survival among cirrhotics. Hepatology 1987;7:660-4.
18. Adler M, Van Laethem J, Glibert A, Gelin M, Bourgeois N, Vereerstraeten P, et al. Factors influencing survival at one year in patients with nonbiliary hepatic parenchyma! cirrhosis. Dig Dis Sei 1990:35:1-5.
19. Merkel C, Gatta A, Zoli M, Bolognesi M, Angeli P, lervese T, et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sei 1991:36:1197-203.
20. Oellerich M, Brudelski M, Lautz HU, Binder L, Pichlmayr R. Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 1991; 14:1029-34.
21. Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992;102:973-9.
22. Marchesini G, Fabbri A, Bugianesi E, Bianchi GP, Marchi E, Zoli M, et al. Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity. Liver 1990:10:65-71.